News

Filter

126 to 135 of 1255 results

New agreement with GSK provides new medicines, saves millions for New Zealand

New agreement with GSK provides new medicines, saves millions for New Zealand

11-12-2013

A new agreement with the local subsidiary of UK pharma giant GlaxoSmithKline by New Zealand’s Pharmaceutical…

Anti-viralsAsia-PacificGlaxoSmithKlineHealthcareHematologyNew ZealandPharmaceuticalPricingRespiratory and PulmonarySeretideSerevent Diskus

GNI Group out-licenses Etuary to AFT Pharma

10-12-2013

Japan headquartered GNI Group, a clinical-stage bio-pharmaceutical company focusing on major diseases…

Asia-PacificLicensingPharmaceuticalRespiratory and Pulmonary

New Zealand funding plans for Tarceva and Revolade

New Zealand funding plans for Tarceva and Revolade

09-12-2013

Following a consultation, New Zealand’s Pharmaceutical Management Agency PHARMAC said this morning…

Asia-PacificGlaxoSmithKlineHematologyNew ZealandOncologyPharmaceuticalPricingRegulationRevoladeRocheTarceva

Medicine prescribing in New Zealand hits new high as PHARMAC role expands

07-12-2013

New Zealanders have gained greater access to medicines in 2013, and record numbers of New Zealanders…

Asia-PacificHealthcareNew ZealandPharmaceuticalRegulation

Should patients appreciate pharma?

Should patients appreciate pharma?

06-12-2013

Here's our take on the week's top stories.

Asia-PacificBayerEuropeFinancialHealthcareManagementPharmaceutical

Review of key drivers of migraine market growth through 2022

06-12-2013

Use of Allergan’s Botox (botulinum toxin type A) for the prophylactic treatment of chronic migraine…

AllerganAsia-PacificBotoxCoLucid PharmaceuticalsEuropelasmiditanLevadexMarkets & MarketingNeurologicalNorth AmericaPharmaceutical

Report 5: Growth strategies in Japan’s pharma market - Research & Development – by P Reed Maurer

Report 5: Growth strategies in Japan’s pharma market - Research & Development – by P Reed Maurer

06-12-2013

From the end of World War II until 1973, pharmaceutical patents in Japan were granted for processes rather…

Asia-PacificPatentsPharmaceuticalResearch

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

05-12-2013

Revealing an earlier agreement yesterday, Israel’s Teva Pharmaceutical Industries and Japan’s largest…

Asia-PacificCopaxoneGlatiramer AcetateLicensingNeurologicalPharmaceuticalRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

Report 4: Growth strategies in Japan’s pharma market – Products – by P Reed Maurer

Report 4: Growth strategies in Japan’s pharma market – Products – by P Reed Maurer

05-12-2013

Japan has a long history of rewarding innovation across many industrial sectors, including the pharmaceutical…

Asia-PacificMarkets & MarketingPharmaceuticalPricing

126 to 135 of 1255 results

COMPANY SPOTLIGHT

Menarini

Back to top